Literature DB >> 24757897

Electronic discharge summaries--are they being done and do they have the required information?

J P Mamo.   

Abstract

A retrospective audit was conducted to evaluate the completeness of the available electronic discharge summaries. Forty-five randomly selected patients had their respective electronic discharge summaries reviewed including criteria such as length of stay; discharge summary availability; documentation of discharge medications; medication changes; medical co-morbidities and follow-up arrangements. There were electronic discharge summaries available for thirty-six (80%) of the included patients of which; thirty-three (91.7%) had the medication list available; twenty-six (72.2%) had clear documentation of medication changes; thirty-five (97.2%) had clear documentation of the patients' co-morbidities; and thirty (83.3%) had clear follow-up plans documented. The readmission rate was found to be high when compared to published numbers with a quarter of the discharged patients being readmitted within 28 days. The recommendations resulting from this audit include the need for improved education on the requirements of the electronic dischange summary, appropriate documentation and possible implementation of out-of-hour discharge summary availability.

Entities:  

Mesh:

Year:  2014        PMID: 24757897

Source DB:  PubMed          Journal:  Ir Med J        ISSN: 0332-3102


  2 in total

1.  From Inpatient Notes to Outpatient Followup: Enhancing the Rhinology Service in a Tertiary Centre through Student Led Projects.

Authors:  M Sayma; R Hyne; M Sharma; L Kyle; M Abo Khatwa; I MacKay-Davies; A Poulios; H S Khalil
Journal:  Int J Otolaryngol       Date:  2015-08-06

2.  The Discharge Communication Study: research protocol for a mixed methods study to investigate and triangulate discharge communication experiences of patients, GPs, and hospital professionals, alongside a corresponding discharge letter sample.

Authors:  Katharine Weetman; Jeremy Dale; Emma Scott; Stephanie Schnurr
Journal:  BMC Health Serv Res       Date:  2019-11-11       Impact factor: 2.655

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.